PURPOSE: To evaluate intervertebral disc (IVD) degeneration and treatments, an objective diagnostic tool is needed. Recently, T2* relaxation time mapping was proposed as a technique to assess early IVD degeneration, yet the correlation with biochemical content and histological features has not been investigated previously. Our objective was to validate T2* mapping for disc degeneration by correlating this technique with accepted parameters of IVD degeneration. METHODS: Mildly and severely degenerated lumbar discs were obtained from an in vivo large animal study; two healthy goat spines were acquired as control. In total, 48 IVDs were analysed using T2-weighted MRI, T2* relaxation time mapping, biochemical assays, macroscopic and histological scoring. Correlations between variables were expressed with Spearman's rho (ρ) coefficients. RESULTS: A complete range of degenerative grades were obtained (mean histological grade 2.2, range 0-6). A linear positive correlation was observed between T2* relaxation time and glycosaminoglycan content (ρ = 0.64, p < 0.001). T2* relaxation time decreased linearly with increasing degeneration as assessed with Pfirrmann scoring system (ρ = -0.67, p < 0.001), macroscopic (ρ = -0.33, p < 0.05) and histological (ρ = -0.45, p < 0.05) grading. CONCLUSIONS: T2* mapping is an MRI technique for IVD evaluation which allows for measurements on a continuous scale thus minimising observer bias compared to grading systems. Although limited by a small sample size, this study showed a relatively good and linear correlation between T2* relaxation time and accepted parameters of disc degeneration. This suggests that T2* mapping is a promising tool to assess disc degeneration in clinical practice.
PURPOSE: To evaluate intervertebral disc (IVD) degeneration and treatments, an objective diagnostic tool is needed. Recently, T2* relaxation time mapping was proposed as a technique to assess early IVD degeneration, yet the correlation with biochemical content and histological features has not been investigated previously. Our objective was to validate T2* mapping for disc degeneration by correlating this technique with accepted parameters of IVD degeneration. METHODS: Mildly and severely degenerated lumbar discs were obtained from an in vivo large animal study; two healthy goat spines were acquired as control. In total, 48 IVDs were analysed using T2-weighted MRI, T2* relaxation time mapping, biochemical assays, macroscopic and histological scoring. Correlations between variables were expressed with Spearman's rho (ρ) coefficients. RESULTS: A complete range of degenerative grades were obtained (mean histological grade 2.2, range 0-6). A linear positive correlation was observed between T2* relaxation time and glycosaminoglycan content (ρ = 0.64, p < 0.001). T2* relaxation time decreased linearly with increasing degeneration as assessed with Pfirrmann scoring system (ρ = -0.67, p < 0.001), macroscopic (ρ = -0.33, p < 0.05) and histological (ρ = -0.45, p < 0.05) grading. CONCLUSIONS: T2* mapping is an MRI technique for IVD evaluation which allows for measurements on a continuous scale thus minimising observer bias compared to grading systems. Although limited by a small sample size, this study showed a relatively good and linear correlation between T2* relaxation time and accepted parameters of disc degeneration. This suggests that T2* mapping is a promising tool to assess disc degeneration in clinical practice.
Authors: Goetz Hannes Welsch; Siegfried Trattnig; Tatjana Paternostro-Sluga; Klaus Bohndorf; Sabine Goed; David Stelzeneder; Tallal Charles Mamisch Journal: Skeletal Radiol Date: 2010-09-28 Impact factor: 2.199
Authors: Sven Hoppe; Sebastian Quirbach; Tallal C Mamisch; Fabian G Krause; Stefan Werlen; Lorin M Benneker Journal: Eur Radiol Date: 2012-04-29 Impact factor: 5.315
Authors: Arin M Ellingson; Hitesh Mehta; David W Polly; Jutta Ellermann; David J Nuckley Journal: Spine (Phila Pa 1976) Date: 2013-11-15 Impact factor: 3.468
Authors: Joshua D Auerbach; Wade Johannessen; Arijitt Borthakur; Andrew J Wheaton; Carol A Dolinskas; Richard A Balderston; Ravinder Reddy; Dawn M Elliott Journal: Eur Spine J Date: 2006-03-22 Impact factor: 3.134
Authors: Cornelis P L Paul; Hendrik A Zuiderbaan; Behrouz Zandieh Doulabi; Albert J van der Veen; Peter M van de Ven; Theo H Smit; Marco N Helder; Barend J van Royen; Margriet G Mullender Journal: PLoS One Date: 2012-03-13 Impact factor: 3.240
Authors: Mary H Foltz; Robert M O'Leary; Diana Reader; Nicholas L Rudolph; Krista A Schlitter; Jutta Ellermann; Casey P Johnson; David W Polly; Arin M Ellingson Journal: Spine Deform Date: 2020-05-24
Authors: Sharon Brown; Samantha Rodrigues; Christopher Sharp; Kelly Wade; Neil Broom; Iain W McCall; Sally Roberts Journal: Eur Spine J Date: 2016-04-15 Impact factor: 3.134